Rapamycin is an immunosuppressive agent widely used to prevent transplant rejection in organ recipients. Its primary mechanism of action involves inhibition of mTOR signaling through complex formation with FK-binding protein 12 (FKBP12), which prevents mTOR activation. As a result, IL-2–mediated ...